Oncophage, the
therapeutic vaccine for kidney
cancer developed by Pramod Srivastava, is approved in Russia, making it the first
therapeutic vaccine worldwide to be approved for patients.
Through the CIC program, the
Cancer Research Institute conducts a number of important initiatives that seek among other things to build consensus across the field on key issues, to develop and implement new standards for carrying out and reporting immunological monitoring assays of therapeutic cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunother
Cancer Research Institute conducts a number of important initiatives that seek among other things to build consensus across the field on key issues, to
develop and implement new standards for carrying out and reporting immunological monitoring assays of
therapeutic cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunother
cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of
cancer immunother
cancer immunotherapies.